Welcome to Hmobio!Global leader in active molecules.
Find Your Distributors

Select Your Country or Region

 $ USD

For research purposes only. Not for human experiments
You are here:Home-Research Areas-Infection-SARS-CoV Infection

Request The Product List ofSARS-CoV Infection SARS-CoV Infection

Severe acute respiratory syndrome (SARS) is an acute respiratory infectious disease caused by SARS coronavirus (SARS CoV). The World Health Organization (who) named it as SARS. The disease is a respiratory infectious disease, the main mode of transmission is close to the spread of droplets or contact with respiratory secretions of patients.

Cat. No. Product Name CAS No. Information
H9433

Enpatoran hydrochloride

 		2101945-93-9

Enpatoran (M5049) hydrochloride is a potent, orally active and dual TLR7/8 inhibitor with IC50s of 11.1 nM and 24.1 nM in HEK293 cells, respectively; Enpatoran hydrochloride is inactive against TLR3, TLR4 and TLR9. Enpatoran hydrochloride can block molecule synthetic ligands and natural endogenous RNA ligands. Enpatoran hydrochloride exhibits excellent pharmacokinetic properties in vivo. Enpatoran hydrochloride can be used for both innate and adaptive autoimmunity blocking research.
H9366

Zavegepant hydrochloride

 		1414976-20-7

Zavegepant is a potent human CGRP antagonist with Ki of 22.7 pM.
H9365

Zavegepant

 		1337918-83-8

Zavegepant is a potent human CGRP antagonist with Ki of 22.7 pM.
H9280

Naproxcinod

 		163133-43-5

Naproxcinod, a Cyclooxygenase-Inhibiting Nitric Oxide (NO)-Donating (CINOD) naproxen, is a non-steroidal anti-inflammatory product candidate originally.
H9278

WP 1122

 		155196-44-4

WP 1122 is a potent coronavirus spike glycoprotein modulators.
H9275

Brilacidin

 		1224095-98-0

Brilacidin is an investigational new drug (IND), is a polymer-based antibiotic currently in human clinical trials, and represents a new class of antibiotics called host defense protein mimetics, or HDP-mimetics, which are non-peptide synthetic small molecules modeled after host defense peptides (HDPs).
H9274

PF-07304814

 		2468015-78-1

Lufotrelvir(PF07304814) is a novel phosphate prodrug for PF-00835231,PF-07304814 rapidly undergoes in vivo conversion to the active metabolite PF-00835231. The phosphate prodrug is weakly acidic, with pKas of 1 and 6.4, and a predicted LogD7.4 of -3.7
H9271

AT-527

 		2241337-84-6

AT-527 is a novel modified guanosine nucleotide prodrug inhibitor of the hepatitis C virus (HCV) NS5B polymerase, with increased in vitro antiviral activity compared to sofosbuvir and a highly differentiated favorable preclinical profile compared to other anti-HCV nucleoside/nucleotide analogs.
H9217

AMY-101

 		1427001-89-5

AMY-101 is a peptidic inhibitor of the central complement component C3 (KD = 0.5 nM), inhibits naturally occurring periodontitis in non-human primates (NHPs); AMY-101 (Cp40) exhibits a favorable anti-inflammatory activity in models with COVID-19 severe pneumonia with systemic hyper inflammation.
H9141

Nicotinamide riboside

 		1341-23-7

Nicotinamide riboside is an orally active NAD+ precursor, increases NAD+ levels and activates SIRT1 and SIRT3. Nicotinamide riboside is a source of vitamin B3 (niacin) and enhances oxidative metabolism, protection against high fat diet-induced metabolic abnormalities. Nicotinamide riboside reduces cognitive deterioration in a transgenic mouse model of Alzheimer’s disease.

Request The Product List

* Indicates a Required FieldYour information is safe with us.

  • *Product List:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Country:
  • Additional Information:
© Copyright 2020 HmoBio. All Rights Reserved. Products are only for research use
沪ICP备2020027822号-1